CD274 and neoplasm: TRT led to an acute increase in programmed death-ligand 1 (PD-L1) expression by T cells, and a combination of TRT and an anti-PD-L1 monoclonal antibody (mAb) stimulated cluster of differentiation-positive (CD8+) T cell infiltration for local tumor control and overall survival.